OA01.09 Adjuvant Osimertinib in Resected EGFR-Mutated Stage IB–IIIA Non-Small Cell Lung Cancer: Updated ADAURA Results
Herbst, R.S., Wu, Y.-L., Grohe, C., John, T., Majem, M., Wang, J., Kato, T., Goldman, J.W., Kim, S.-W., Yu, C.-J., Vu, H.V., Mukhametshina, G., Akewanlop, C., de Marinis, F., Shepherd, F.A., Urban, D., Stachowiak, M., Bolanos, A., Huang, X., Tsuboi, M.
Published in Journal of thoracic oncology (01.03.2023)
Published in Journal of thoracic oncology (01.03.2023)
Get full text
Journal Article
356MO Osimertinib adjuvant therapy in patients (pts) with resected EGFR-mutated (EGFRm) NSCLC (ADAURA): Central nervous system (CNS) disease recurrence
Tsuboi, M., Wu, Y-L., He, J., John, T., Grohe, C., Majem, M., Goldman, J.W., Laktionov, K., Kim, S-W., Kato, T., Vu, H.V., Akewanlop, C., Yu, C-J., de Marinis, F., Domine, M., Shepherd, F.A., Yan, C., Atasoy, A., Herbst, R.
Published in Annals of oncology (01.11.2020)
Published in Annals of oncology (01.11.2020)
Get full text
Journal Article
LBA1 Osimertinib adjuvant therapy in patients (pts) with resected EGFR mutated (EGFRm) NSCLC (ADAURA): Central nervous system (CNS) disease recurrence
Tsuboi, M., Wu, Y-L., He, J., John, T., Grohe, C., Majem, M., Goldman, J.W., Laktionov, K., Kim, S-W., Kato, T., Vu, H.V., Akewanlop, C., Yu, C-J., de Marinis, F., Domine, M., Shepherd, F.A., Yan, C., Atasoy, A., Herbst, R.
Published in Annals of oncology (01.09.2020)
Published in Annals of oncology (01.09.2020)
Get full text
Journal Article
OA06.03 Patient-Reported Outcomes from ADAURA: Osimertinib as Adjuvant Therapy in Patients with Resected EGFR Mutated (EGFRm) NSCLC
Majem, M., Goldman, J., John, T., Grohe, C., Laktionov, K.K., Kim, S., Kato, T., Vu, H.V., Lu, S., Lee, K.Y., Akewanlop, C., Yu, C., De Marinis, F., Bonanno, L., Domine, M., Shepherd, F., Zeng, L., Kulkarni, D., Medic, N., Tsuboi, M., Herbst, R., Wu, Y.
Published in Journal of thoracic oncology (01.03.2021)
Published in Journal of thoracic oncology (01.03.2021)
Get full text
Journal Article
OA06.04 Postoperative Chemotherapy Use and Outcomes from ADAURA: Osimertinib as Adjuvant Therapy for Resected EGFR Mutated NSCLC
Wu, Y., John, T., Grohe, C., Majem, M., Goldman, J., Kim, S., Kato, T., Laktionov, K.K., Vu, H.V., Wang, Z., Lu, S., Lee, K.Y., Akewanlop, C., Yu, C., De Marinis, F., Bonanno, L., Domine, M., Shepherd, F., Zeng, L., Atasoy, A., Herbst, R., Tsuboi, M.
Published in Journal of thoracic oncology (01.03.2021)
Published in Journal of thoracic oncology (01.03.2021)
Get full text
Journal Article
Pembrolizumab-induced Stevens-Johnson syndrome/Toxic Epidermal Necrolysis in a Vietnamese patient with nonsmall-cell lung cancer
Pham, Yen T.H., Vu, Mai T., Nguyen, Anh Q., Trinh, Phat N., Tran, Mai H., Chu, Hieu C., Nguyen, Nguyet T.M., Vu, Chi H.V., Nguyen, Dinh V.
Published in Asia Pacific allergy (18.12.2023)
Published in Asia Pacific allergy (18.12.2023)
Get full text
Journal Article
Role of Nitric Oxide in the Pathogenesis of a Preeclampsia-Like Syndrome in Rats
Ianosi-Irimie, M., Whitbred, J.M., Vu, H.V., Pridjian, C.A., Pridjian, G., Puschett, J.B.
Published in Journal of investigative medicine (01.01.2005)
Published in Journal of investigative medicine (01.01.2005)
Get full text
Journal Article